drug binding and transport. Herein we describe the moThough the quality of the model based on the 1.3 Å lecular architecture of the native MRD protein and the SeMet dataset was good, the density presumed to corstructural details of the complex of MRD with 1,2-cisrespond to the ligand was deemed unsatisfactory. 1-hydroxy-2,7-DAM, which binds to MRD with an assoTherefore, the experiment was repeated, and 1.5 Å resociation constant that is five times higher than that of lution data were collected from another SeMet-con-MC. MRD is a dimer, with each monomer containing a taining crystal that was soaked for a longer period in tandem repeat of ␤␣␤␤␤ modules. Two different modes the presence of MC. Subsequent refinement against of dimer formation are observed, suggesting a domainthese data revealed full occupancy for a bound ligand, swapping event. The drug binding sites are located in which proved to be 1,2-cis-1-hydroxy-2,7-DAM (see bedeep clefts on the opposite sides of the molecule and low for further details of the chemistry). The final, refined formed either by the curvature of the ␤ sheet within a model of the complex is derived from this 1.5 Å data monomer or, when domain swapping occurs, by two set.
␤␣␤␤␤ modules from adjacent monomers. The drug is
In all three crystal structures, a single monomer occusandwiched by -stacking interactions between the pies the asymmetric unit of the C2 unit cell, and two protonated imidazole of His-38 and the indole ring of monomers form a close association with the resultant Trp-108.
2-fold axis of the MRD dimer corresponding to the crystallographic dyad. This is consistent with our gel filtraResults and Discussion
tion results (data not shown), which indicate that a dimer is the predominant species in solution. For all three Structure Determination and Model Quality refined models, each monomer contains residues 3-130, MRD was overexpressed in E. coli, purified, and crystalinclusive, with the region containing residues 65-71 belized as described in Experimental Procedures. The use ing comparatively less well ordered. Residues in this of the MAD phasing technique based on SeMet was region were not included until final refinement, for realimited due to the presence of only one Met residue. sons explained below. There are 153, 161, and 158 orTherefore, we designed a double mutant in which Leudered water molecules included in the final models for 19 and Leu-25 were replaced by methionine residues. the ligand-bound, apo form, and 1.3 Å resolution strucCrystals of the SeMet containing double mutant diftures, respectively. In the case of the complex structure, fracted beyond 1.3 Å resolution (see Table 1 ). For experia molecule of 1,2-cis-1-hydroxy-2,7-DAM was modeled mental phasing, we used a single data set collected at into residual positive difference electron density and the absorption peak of Se (0.979 Å ) from a crystal soaked included late in refinement. The known geometry of the for two days in the mother liquor containing MC (see quinone ring was used as a restraint, while the remaining Experimental Procedures). The positions of the three moieties were restrained using standard bond lengths methionine residues were readily determined and aland angles. lowed for the calculation of preliminary phases. The
The quality of the models, as judged by stereochemiinitial model was created using ARP/wARP [21], which cal criteria, is high (see Table 2 ), and PROCHECK [23] automatically built 110 out of a total of 130 residues, analysis indicates that approximately 95% of the resiand refined with SHELXL [22]. Additionally, a complete dues in the final models are in the most favored regions data set to 1.5 Å was first collected from a crystal of the wild-type and unliganded protein.
with no outliers. to suggest that the domain-swapping events may be 31], is that the N-terminal modules superpose on each dynamic, so that the two forms may coexist in solution, other better than on the C-terminal motifs and vice versa.
while crystallization selectively isolates either one or Although in all three structures the MRD dimer conthe other. Whether this is a consistent feature of other sists of two pairs of domains A and B related by crystalproteins in the family remains to be seen. lographic symmetry, alternative connectivities between these domains give rise to two topologically distinct
The Bound MC Derivative Is 1,2-cis-1-Hydroxyforms generated by a 3D domain-swapping phenome-2,7-DAM non. Our electron density indeed corroborates that both MRD crystals turn pink when soaked for a few days in species are present, albeit each crystal form selects mother liquor solution containing crystalline MC. Bepreferentially for one. In form I, observed in wild-type cause MC is purple, with a visible absorbance spectrum unliganded MRD, each monomer consists of a continushowing a single peak at 360 nm, the pink color sugous eight-stranded sheet, and the back to back interface gested the appearance of a compound closely related to between the eight-stranded sheets establishes the inter-2,7-diaminomitosene, with a characteristic absorbance face between the two monomers. In form II, found in both peak at 313 nm. The initial 1.3 Å data set, derived from drug-bound SeMet-containing crystals, each monomer crystals soaked for two days, yielded a region of density contributes half of each of the two eight-stranded sheets suggestive of a bound ligand, albeit of poor quality. The in the dimer (Figure 4) . The structural differences be-1.5 Å data set, obtained from a crystal soaked for four tween these forms result from a simple change in the days, yielded very well-defined electron density for the linker connecting the two domains. In form I, residues bound drug. We noted that there was no electron density 67-69 form two turns, which face each other as symmeassociated with the methoxy substituent at C9a of MC, try-related structures. In form II, proline 67 and threonine and the region corresponding to C9 carbon clearly 68 are in an extended conformation and form two linear strands going in opposite directions.
showed the flattened sp 2 hybridization, with the substit- 
Experimental Procedures
Binding Assays Dissociation constants (K d ) were determined by fluorimetric titration of MRD wild-type and its two mutant forms (D52N and Y112F) with Expression of MRD in E. coli The mrd gene was subcloned into an expression vector used to increasing concentrations of drug (MC or DAM). To determine the dissociation constant, increasing amounts of the drug were added create a GST fusion protein with an rTEV proteolytic cleavage site (pGST-Parallel1) [38] . Aggregation difficulties with the MRD-GST to a constant concentration of the MRD. In each case eight to ten data points were collected. Experiments were done in duplicate at fusion protein led us to test samples using size exclusion chromatography. This provided early evidence that MRD was a dimer and 20ЊC using an FP-750 spectrofluorometer (Jasco) under the following conditions: excitation ϭ 280 nm, emission ϭ 342 nm, and that higher-order oligomers of MRD-GST were responsible for aggregation. The mrd gene was then subcloned into a His 6 -tag expresexcitation and emission slit width ϭ 5 nm. MC or 1-hydroxy-DAM (2 M-0.7 mM) were added to 1200 l of 1.8 M MRD in 100 mM sion vector (pHis Parallel1) [38] . The sequence-verified plasmid was transformed into E. coli BL21(DE3) (Novagen). The cells were grown MES (pH 6.0). The residual protein fluorescence was measured after 100 min incubation. The dissociation constants were determined as at 37ЊC in 1 liter of LB broth containing 100 g/ml ampicillin to an OD 600 of 0.6-0.8, and expression was initiated by the addition of described previously [39] . 
